Stockreport

Journey Medical Corp (DERM) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]

Journey Medical Corporation  (DERM) 
Last journey medical corporation earnings: 11/5 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.dermira.com
PDF Net Product Revenue Growth: 11% for the full year 2025. Gross Margin: Improved to 66.2% from 62.8% in 2024. SG&A Expenses: $44.4 million, up 10% from $40.2 million [Read more]